Association of CYP2C19*2 polymorphism with clopidogrel resistance among patients with high cardiovascular risk in Northeastern Mexico.

Conclusion: The presence of the CYP2C19*2 allele is related to resistance to the antiplatelet effect of CLO (p = 0.003). PMID: 31834317 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/31834317?dopt=Abstract

Source: Archivos de Cardiologia de Mexico - December 15, 2019 Category: Cardiology Authors: Cedillo-Salazar FR, Martínez-Jacobo L, Pérez-Páramo YX, Cerda-Flores R, Martínez LE, Jaime-Pérez JC, Moreno-Treviño MG, Pérez-Rodríguez E, Bosques-Padilla FJ, Cedillo-Avila M, Cedillo-Avila MA, Zamudio-Osuna M Tags: Arch Cardiol Mex Source Type: research